While doctors write more than 200 million prescriptions for statins each year, adherence to treatment remains a significant issue. Previous studies indicate that nearly 75% of new statin users stop therapy by the end of the first year.
Problems with statin adherence are associated with an increased risk of adverse cardiovascular outcomes—including heart attack and death and contribute to the rising costs of heart disease; expected to reach $818 billion by 2030.
TV personality John O’Hurley joins the National Lipid Association (NLA), Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company, in announcing the results of USAGE, “Understanding statin use in America and Gaps in Education,” the largest known U.S. survey involving more than 10,100 statin users.
For the first time, the USAGE survey helps educate the medical and patient communities about the behaviors and attitudes of statin users and the reasons why patients stop taking their Statin medications.
For more information about this program, check out this site: www.statinUSAGE.com